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Abstract
Background
The objective of the study was to evaluate the implications of different classifications of
rheumatic heart disease on estimated prevalence, and to systematically assess the impor-
tance of incidental findings from echocardiographic screening among schoolchildren in
Peru.
Methods
We performed a cluster randomized observational survey using portable echocardiography
among schoolchildren aged 5 to 16 years from randomly selected public and private schools
in Arequipa, Peru. Rheumatic heart disease was defined according to the modifiedWorld
Health Organization (WHO) criteria and theWorld Heart Federation (WHF) criteria.
Findings
Among 1395 eligible students from 40 classes and 20 schools, 1023 (73%) participated in
the present survey. The median age of the children was 11 years (interquartile range [IQR]
8–13 years) and 50% were girls. Prevalence of possible, probable and definite rheumatic
heart disease according to the modified WHO criteria amounted to 19.7/1000 children and
ranged from 10.2/1000 among children 5 to 8 years of age to 39.8/1000 among children 13
to 16 years of age; the prevalence of borderline/definite rheumatic heart disease according
to the WHF criteria was 3.9/1000 children. 21 children (2.1%) were found to have congenital
heart disease, 8 of which were referred for percutaneous or surgical intervention.
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Conclusions
Prevalence of RHD in Peru was considerably lower compared to endemic regions in sub-
Saharan Africa, southeast Asia, and Oceania; and paralleled by a comparable number of
undetected congenital heart disease. Strategies to address collateral findings from echocar-
diographic screening are necessary in the setup of active surveillance programs for RHD.
Trial Registration
ClinicalTrials.gov identifier: NCT02353663
Introduction
Rheumatic fever results from an abnormal autoimmune response to group A streptococcal
pharyngitis and may progress to rheumatic heart disease (RHD) with cumulative exposure.
Largely eliminated in high-income countries, RHD continues to be endemic in less privileged
regions of the world where it accounts for up to a quarter million premature deaths every year
[1][2].
Screening echocardiography for early detection of clinically silent rheumatic heart disease
(RHD) has been recommended in endemic regions of the world, where RHD accounts for up
to a quarter of a million deaths every year.[3] [1] Timely installation of secondary antibiotic
prophylaxis may prevent progression of subclinical lesions to severe valvular damage and heart
failure mediated by cumulative exposure to streptococcal antigens.
Differences in the criteria for the diagnosis of RHD contribute to the large heterogeneity in
reported prevalence across different geographical regions, and may translate into a differential
in timing of initiation of secondary antibiotic prophylaxis. Valvular lesions consistent with
RHD progress along a spectrum of disease and involve isolated morphological changes of the
valvular apparatus, functional lesions, or a combination of both. The prognostic significance of
the individual stages needs to be determined in prospective studies of the natural history of
subclinical valvular disease.
Moreover, the implications of population-based echocardiographic screening reach beyond
the detection of RHD. Several studies using echocardiographic screening reported incidental
findings of congenital heart disease. The latter may have repercussions on medical manage-
ment and prognosis that have not been systematically assessed to date. In resource-limited set-
tings high prevalence rates of RHD are paralleled by constrained access to healthcare, and
regular medical examinations of children and adolescents are few. The importance of collateral
findings from active surveillance for RHD on prognosis and healthcare expenditures in emerg-
ing countries may be underestimated.
The objective of the present analysis was to (1) evaluate the implications of different classifi-
cations of RHD on estimated prevalence, and (2) to systematically assess the importance of
incidental findings from echocardiographic screening among schoolchildren in Peru.
Methods
Study design and patient population
We performed a cross-sectional survey of RHD among school-going children in Arequipa.
Peru has a Human Development Index (HDI) of 0.737 and ranks at 82 among all 187 listed
countries in the Human Development Report issued by the United Nations Development
Rheumatic Heart Disease in Peru
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Programme[4]. Arequipa is situated at 2328 meters altitude above sea level and links the coastal
and highland regions of southern Peru. We identified 457 primary and secondary schools.
Using a multistage sample strategy we selected 40 classes from 20 schools for the present survey
taking into account administration of the schools (governmental versus private) and the loca-
tion in an urban or rural setting, respectively. Two classes per school were selected. All children
from a selected class between 5 and 16 of years of age were eligible for potential inclusion. No
exclusion criteria applied.
Ethics statement
Ethical approval was obtained from the Human Research Ethics Committee of the University
San Martín de Porres, Lima, Peru (Officio No. 48-2014-CIEI-USMP-CCM). Local authoriza-
tions were granted by the Regional Administrations of the Health and Education Ministries, as
well as from each school’s principal. Written consent was obtained from parents/guardians,
and written assent from all children. The study was registered with ClinicalTrials.gov (Identi-
fier: NCT02353663).
Data acquisition and echocardiographic evaluation
All selected schools were contacted and visited to inform the major stakeholders, outline the
objective of the project, and gather informed consent. Subsequently, all selected classes were
visited at least twice by a team of two physicians and one study nurse in order to reduce the
number of absentees to a minimum. Demographic and socio-economic characteristics were
acquired in a standardized interview by means of a questionnaire customized to the age of the
children. A focused medical history was followed by a brief physical examination. Cardiac aus-
cultation and echocardiographic screening were performed by two independent physicians
blinded to the findings of each other. Echocardiography was performed by a specifically trained
cardiologist following a structured acquisition protocol according to the WHF recommenda-
tions for acquisition[5]. A complete two-dimensional echocardiography with parasternal,
apical, subcostal and suprasternal views, and M-mode and Doppler imaging was used for
diagnosis (S1 Fig). A MyLabAlpha (Esaote, Italy) portable echocardiographic device and
MyLabDesk3 (Esaote, Italy) software were utilized. Subjects with pathologic findings were re-
scheduled for a detailed clinical and echocardiographic evaluation by a local cardiologist. Chil-
dren with echocardiographic findings compatible with borderline or definite RHD according
to the WHF criteria, or probable or definite RHD according to the WHO criteria, were invited
to initiate secondary prophylaxis and regular follow-up. Patients with other diagnoses (e.g.
congenital heart disease) were given professional advice according to the need of follow-up,
medical or invasive treatment, and referred to the local health providers. Stored clips of all sub-
jects were further evaluated in the echocardiographic corelab at Bern University Hospital, and
measurements required for the WHF andWHO criteria were re-assessed by 5 cardiologists.
Disagreements in the assessment of criteria used for diagnosis and categorization of RHD were
resolved by discussion; a final diagnosis was reached after mutual agreement between reviewers
or a final decision by a third party. All clips and still frames were captured and analysed using
harmonics. Data was entered into a dedicated database held at the Institute of Social and Pre-
ventive Medicine at the University of Bern, Switzerland. Central data monitoring was per-
formed. We assessed the inter-rater reliability of the echocardiographic measurements in a
subset of 120 screening echocardiograms using 6 raters.
Rheumatic Heart Disease in Peru
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Definitions
Acute rheumatic fever (ARF) was defined according to the Jones criteria.[6] RHD was defined
according to the modified criteria of the WHO and the criteria of the WHF for individuals<20
years of age (S1 Table). In brief, the modified WHO criteria take into account both cardiac
murmurs consistent with any combination of mitral regurgitation or aortic regurgitation and
morphological or functional findings on echocardiography. In contrast, the criteria suggested
by the World Heart Federation (WHF) rely on echocardiographic findings only and require a
combination of morphological and functional criteria[5]. The presence of a pathologic heart
murmur on cardiac auscultation differentiates between clinically manifest and silent disease.
Statistical analysis
Sample size calculations were based on reported prevalence rates of RHD among school chil-
dren in endemic countries using echocardiographic screening. We calculated a sample size of
1000 school children aged 5 to 16, accounting for a type I error of 0.05 and a statistical power
of 80%.
The sampling was performed on the basis of the strategy applied in the international educa-
tional surveys TIMSS and PIRLS, which suggests to use a two-stage stratified sampling proce-
dure.[7] Using this sampling procedure, we selected 40 classes. In the first sampling stage, 20
schools were sampled with probabilities proportional to their size from a list of all schools in
the region of interest. The schools were stratified according to the type of school (public/private
and primary/secondary) as well as their degree of urbanity (rural/urban). With the aim of
ensuring adequate representation of these stratification variables, we opted for explicit stratifi-
cation leading to a split of the sampling frame and thus resulting in eight smaller sampling
frames. The sampling was performed within each of these sampling frames in order to ensure
the desired level of precision in each stratum. The second sampling stage consisted of a random
selection of two classes from each selected schools. The sampling weights account for the
described sampling strategy and include adjustment to non-response at individual level.
Data is presented as counts and percentages for binary and categorical variables and as
means and standard deviations (SD) or medians and interquartile ranges (IQR) for continuous
variables. Height, weight and body mass index (BMI) are reported as corresponding z-scores
for age and were calculated using the application tools made available by the WHO.[8] We esti-
mated the overall prevalence rate of RHD and also calculated age-specific prevalence rates. The
prevalence rates are reported by indicating the 95% confidence interval. The inter-rater reliabil-
ity was assessed individually between the on-site rater and five off-site raters, using the preva-
lence adjusted and bias adjusted Kappa statistic to account for the poor reliability of the Kappa
statistic in case of very low or high prevalence.[9] We assessed possible predictors of RHD
using univariate logistic regression. We performed both an unweighted and weighted analysis
to account for the effect of the sampling strategy on the estimation of the overall prevalence of
RHD. The association between age groups and disease was further assessed using the χ2 test
and the association between disease progression and age using ordered logistic regression. All
analyses were performed using Stata 13 (StataCorp, College Station, TX, USA).
Role of funding source
The study was supported by research grants of the UBS Optimus Foundation and the Gottfried
and Julia Bangerter-Rhyner Foundation. The funder of the study had no role in study design,
data collection, data analysis, data interpretation, or writing of the manuscript. ES and TP
had access to all data in the study and had final responsibility for the decision to submit for
publication.
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Results
Between April and May 2014 a total of 1395 children from 40 classes in 20 randomly selected
schools were invited to undergo active surveillance for rheumatic heart disease. After orienta-
tion of the children and their primary caregivers, 1023 children (73%) between the ages of 5 to
16 years underwent evaluation according to a multistage screening protocol (Fig 1). Detailed
information of the sampling frame and the study sample are provided in the S2 Table.
Socio-demographic characteristics are summarized in Table 1. The median age of the chil-
dren was 11 years (IQR 8–13 years) and 50% were girls. More than four in five children (82%)
were raised in an urban environment, and more than half of the children went to private
schools (57%). The majority of the children (99%) had relatively close access to healthcare facil-
ities (10 km) and reported a visit to the doctor within the last six months in 59% of the cases.
394 children (39%) reported a past medical history of a sore throat (Table 2). Two children
reported migrating arthritis and one child had chorea; however, none of the children qualified
for a diagnosis of ARF according to the Jones criteria. On cardiac auscultation, 44 children
(4.3%) were found to have a heart murmur.
After on-site screening, pathologic findings on echocardiography were reported in 59 chil-
dren (5.8%), out of which 45 underwent a confirmatory echocardiogram (Fig 1). From the
remaining, 2 refused further participation, 1 changed school with no contact details, and 11
missed at least three appointments. Echocardiographic findings are summarized in Table 3. 20
children had findings consistent with definite (n = 1), probable (n = 5) or possible (n = 14)
RHD according to the modified WHO criteria, resulting in a prevalence of 19.7/1000 children.
The sensitivity and specificity of a cardiac murmur to detect RHD were 25% and 96%, respec-
tively. The prevalence of RHD as assessed by the WHO definition increased across age catego-
ries from 10.2/1000 among children 5 to 8 years of age to 39.8/1000 among children 13 to 16
years of age (p = 0.010), and stage of disease numerically increased with advancing age without
reaching statistical significance (p = 0.704) (Fig 2). 4 Children had definite or borderline RHD
according to the WHF criteria, consistent with a prevalence of 3.9/1000. Echocardiographic
details of the WHF criteria are summarised in S3 Table. The prevalence adjusted and bias
adjusted Kappa measuring the inter-rater reliability ranged between 0.82 and 0.95, whereas the
observed agreement was between 91% and 98% (S4 Table). The burden of RHD was paralleled
by the burden of structural congenital heart disease (Table 3). 15 children were found to have
left-to-right shunts through atrial septal defects (ASD, n = 10), patent ductus arteriosus (PDA,
n = 4) or partial anomalous pulmonary venous drainage (n = 1). Additional incidental findings
included 4 bicuspid aortic valves, one double mitral valve orifice, and one left ventricular non-
compaction. Four children had both RHD and congenital heart disease (two had bicuspid
aortic valve, one partial anomalous pulmonary venous drainage, and one ASD). There was a
significant association between congenital heart disease and RHD (p = 0.001). We performed
both an unweighted and weighted logistic regression to assess predictors of RHD according to
the modified WHO criteria (Table 4). The unweighted model revealed that increasing age is
associated with disease (p = 0.016) (consistent with Fig 2). This finding was however not main-
tained in the weighted model.
Management of patients with pathologic findings during screening echocardiography is
summarized in S5 Table. Six children with WHO definite or probable RHD, and one with
WHF borderline RHD were started on secondary antibiotic prevention with intramuscular
benzathine penicillin. Three children with ASDs and right ventricular dilatation were referred
for ASD closure; one additional ASD had already been treated by the time of confirmation. Six
children with small ASDs were scheduled for regular clinical follow-up. Four children found to
have PDAs were referred for percutaneous closure. All children with congenital heart defects
Rheumatic Heart Disease in Peru
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were referred to specialized centres. Economic restrictions obliged the children to wait until
the arrival of international missions who offer free interventions bringing their own materials,
while using local infrastructure.[10]
Discussion
The main findings of our study can be summarized as follows: (1) Prevalence of RHD varied
according to definition applied and ranged from 3.9/1000 for WHF borderline/definite to 19.7/
1000 for WHO possible/probable/definite. (2) Overall prevalence and stage of disease increased
with advancing age. (3) The number of children diagnosed with congenital heart disease paral-
leled the number of children diagnosed with RHD. (4) There was a significant association
between congenital heart disease and RHD. (5) At short-term, the major clinical consequences
Fig 1. Patient flow according to STROBE statement. *4 children had both rheumatic heart disease and congenital heart disease.
doi:10.1371/journal.pone.0133004.g001
Rheumatic Heart Disease in Peru
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Table 1. Socio-demographic characteristics.
Age, years (median [IQR]) 11 (8–13)
Males (%) 510 (49.9)
Socio-economic criteria
Number of rooms
3 rooms 137 (13.4)
4–6 rooms 427 (41.7)
7 rooms 459 (44.9)
Number of family members
Adults per household 3 (2–4)
Children per household 2 (2–3)
Overcrowding (4 persons per room) 6 (0.6)
Possessions
1 car 471 (46.0)
1 motorbike 113 (11.0)
1 television 1019 (99.6)
1 cellular phone 1005 (98.2)
Internet connection 598 (58.5)
10 books 757 (74.0)
Primary caregiver
Age of primary caregiver (e.g. father) 40 (35–45)
Education
Superior education, University 145 (14.2)
Superior education, not University 216 (21.1)
High School Certiﬁcate 603 (58.9)
Primary School or Literate 59 (5.8)
Illiterate 0 (0.0)
Occupation
Retired, disability 10 (1.0)
Unemployed 16 (1.6)
Semi-skilled worker 565 (55.2)
Skilled worker 156 (15.2)
Technical career 137 (13.4)
Professional 139 (13.6)
School
Urban 838 (81.9)
Public 440 (43.0)
Distance to the nearest health care center
<1 km 493 (48.2)
1 to <5 km 435 (42.5)
5 to <10 km 80 (7.8)
10 to <20 km 13 (1.3)
20 km 2 (0.2)
Most recent doctor visit
In the last month 236 (23.1)
In the last 6 months 366 (35.8)
In the last year 208 (20.3)
In the last 2 years 71 (6.9)
More than 2 years ago 142 (13.9)
doi:10.1371/journal.pone.0133004.t001
Rheumatic Heart Disease in Peru
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Table 2. Physical examination.
Height for age z-score -0.43±1.03
Weight for age z-score* 0.78±1.25
BMI (kg/m2) for age z-score 1.05±1.15
Body surface area (m2) 1.3 (1.0–1.5)
Waist circumference 71.0 (64.0–78.0)
Heart rate (bpm) 81 (74–85)
Oxygen saturation (%) 96 (95–97)
Cardiac murmur 44 (4.3)
Systolic 41 (4.0)
Diastolic 3 (0.3)
History of sore throat 394 (38.5)
Joint pain 286 (28.0)
Signs of ARF
Migrating arthritis 2 (0.2)
Erythema marginatum 0 (0.0)
Subcutaneous nodules 0 (0.0)
Chorea 1 (0.1)
*z-scores for weight and age are only available up to the age of 120 months.
doi:10.1371/journal.pone.0133004.t002
Table 3. Echocardiographic findings.
Rheumatic heart disease
WHF criteria 4 (0.4)
Deﬁnite RHD 1 (0.1)
Pathologic MR and at least two morphological criteria of RHD of the MV 0 (0.0)
MS mean gradient greater or equal 4 mmHg 0 (0.0)
Pathological AR and at least two morphological features of RHD of the AV 1 (100.0)
Borderline disease of both the AV and the MV 0 (0.0)
Borderline RHD 3 (0.3)
At least two morphological features of RHD of the MV without pathological MR or MS 1 (33.3)
Pathological MR 1 (33.3)
Pathological AR 1 (33.3)
WHO criteria 20 (2.0)
Deﬁnite RHD 1 (0.1)
Probable RHD 5 (0.5)
Possible RHD 14 (1.4)
Congenital heart disease
Atrial septal defects 10 (1.0)
Partial anomalous pulmonary venous drainage 1 (0.1)
Bicuspid aortic valve 4 (0.4)
Double mitral valve oriﬁce 1 (0.1)
Patent ductus arteriosus 4 (0.4)
Left ventricular noncompaction 1 (0.1)
MR = mitral regurgitation, MV = mitral valve, MS = mitral stenosis, AR = aortic regurgitation, AV = aortic
valve.
doi:10.1371/journal.pone.0133004.t003
Rheumatic Heart Disease in Peru
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of echocardiographic screening were related to congenital heart disease rather than to RHD.
The long-term effect of echocardiographic screening for RHD needs to be determined.
The observed prevalence of RHD differentiates Peru from truly endemic regions in sub-
Saharan Africa, Southeast Asia, and Oceania where several-fold higher prevalence rates have
been reported[3]. Data on prevalence of RHD in Latin America are scarce and range from 1.3/
1000 (95% CI 0.3 to 5.9) as assessed by cardiac auscultation to 4.1/1000 (95% CI 2.4–7.1) as
assessed by echocardiography1. In a predominantly urban setting in Peru, we documented a
prevalence rate of 3.9 to 19.7/1000 depending on the definition applied. Prevalence according
to the WHF criteria was hence comparable to the reported prevalence in low-risk non-Indige-
nous children in Australia[11]. Previous analyses suggested a higher prevalence of RHD in
rural settings.[12] [13] Our findings of a higher prevalence of RHD according to the WHO
compared to the WHF criteria are consistent with a previous report from Fiji.[14] While the
Fig 2. WHO stage of disease according to age categories from 5 to 8 years, 9 to 12 years and 13 to 16
years. Light grey indicated possible RHD, grey indicates probable RHD, and dark grey indicates definite
RHD according to the modifiedWHO classification. The association between RHD according to the modified
WHO classification and the age groups was assessed using the χ2 test (p = 0.010). The association between
disease progression and age was evaluated using unweighted ordered logistic regression (p = 0.016) and
weighted ordered logistic regression (p = 0.416).
doi:10.1371/journal.pone.0133004.g002
Table 4. Predictors of rheumatic heart disease.
Unweighted model Weighted model
OR (95%CI) P-value OR (95%CI) P-value
Age 1.24 (1.04–1.48) 0.0160 1.07 (0.87–1.32) 0.5326
Male gender 1.01 (0.42–2.44) 0.9894 1.63 (0.58–4.61) 0.3571
Number of household members 0.92 (0.74–1.14) 0.4628 0.85 (0.68–1.07) 0.1726
Overcrowding 1.20 (0.16–9.21) 0.8579 2.02 (0.26–15.95) 0.5058
Socio-economic score 1.03 (0.82–1.29) 0.7937 0.87 (0.66–1.15) 0.3194
History of sore throat 1.07 (0.43–2.63) 0.8903 1.60 (0.56–4.59) 0.3827
doi:10.1371/journal.pone.0133004.t004
Rheumatic Heart Disease in Peru
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modified WHO criteria are more sensitive, the echocardiographic criteria suggested by the
WHF are more specific. Still, concerns have been raised that the WHF criteria may still poten-
tially include some normal cases in the borderline group.[14] Follow-up studies of subclinical
RHD reported stable findings in a majority of children and progression of disease in 5 to 15%
only[15] [16] [17] [18]; however duration of follow-up was limited to less than 3 years and no
long-term data is available to date. Another issue is related to the reliability of diagnosis of
RHD during screening. The evaluation of the inter-rater agreement indicated differences in the
detection of disease across the five off-site raters. Definition of RHD has important implica-
tions for the initiation of secondary prevention. Little is known about the natural course of
early stages of RHD at this time. Regression has been observed in approximately one third of
subclinical disease and was mainly attributable to regression of mitral regurgitation, whereas
morphological changes tended to be more stable.[15] [16] [17] [19] Long-term studies will be
needed to balance the benefit and risk of secondary antibiotic prevention for early stages of
RHD. In view of the considerable inter-rater variability in echocardiographic detection of early
lesions and documented regression of borderline disease, the burden of disease warranting
population-based echocardiographic screening needs to be determined.
We observed an increasing prevalence of RHD as a function of age in an unweighted analy-
sis. This observation is consistent with the findings of a meta-analysis on active surveillance of
RHD and may underscore the effect of cumulative exposure to group A beta-hemolytic strepto-
coccal infections.[3] None of the children in the youngest age category between 5 to 8 years
was diagnosed with an advanced stage of disease. The number of children with definite or
probable RHD numerically increased with advancing age without reaching statistical signifi-
cance. Data from Senegal and Pakistan suggested an increasing prevalence of advanced stages
of disease with increasing age.[20] [21]
Echocardiographic screening revealed congenital heart disease in 2.1% of children. Are-
quipa is situated at 2328 meters altitude above sea level. Previous studies have shown a higher
prevalence of congenital heart disease in high altitude regions, particularly ASDs and PDAs.
[22] [23] A higher prevalence of PDAs may result from the lower oxygen tension in higher alti-
tudes, preventing the constriction and spontaneous closure of the ductus arteriosus after birth.
[22] A higher prevalence of ASDs has been attributed to the higher pulmonary vascular resis-
tance in altitude; the latter increases right-sided cardiac pressure inhibiting early closure of the
foramen ovale. Prolonged stretching of the fossa ovalis during growth may in turn favour the
formation of an ASD.[24] In addition to a higher prevalence of congenital heart disease at
higher altitudes, the risk of congenital heart disease to be missed at higher altitudes also appears
to be increased. Pulse oxymetry screening for cyanotic congenital heart disease among new-
borns has shown a higher rate of failure at moderate altitude as compared to sea level due to
lower mean oxygen saturations at higher altitude.[25] Moreover, economic restraints might
prevent regular or detailed examinations of children. As a consequence, echocardiographic
screening of school children may reveal congenital heart disease that could have been detected
in postnatal exams or early childhood in wealthy countries.
The presence of congenital heart disease was associated with RHD in our study. This finding
may be a chance finding; in view of the small numbers our analysis is not robust enough to pos-
tulate an association between RHD and congenital heart disease. Furthermore, a diagnosis of
RHD has to be made with caution among subjects with congential heart disease involving the
same structures that are also affected by RHD. Moreover, this observation may be biased by the
fact, that children with suspicious findings for RHDmay have undergone more detailed echo-
cardiographic evaluation. This in turn may have increased the likelihood of being diagnosed
with incidental congenital heart disease. However, the uniform application of a pre-specified
comprehensive echocardiographic acquisition protocol including a rule-out list for congenital
Rheumatic Heart Disease in Peru
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abnormalities reduces the chances of a selection bias. While the prevalence of congenital heart
disease numerically paralleled the prevalence of RHD, the severity of disease was greater. Eight
children required intervention for congenital heart disease whereas none of the children with
RHD was found to be in a stage requiring intervention beyond secondary prevention. The
short-term effect of screening was determined by collateral findings rather than RHD. As a
consequence, strategies to address collateral findings from echocardiographic screening are
necessary in the setup of active surveillance programs for RHD. The long-term effect of echo-
cardiographic detection of clinically silent RHD needs to be determined in prospective studies.
The present analysis has several limitations. First, the sample size was limited, the number of
children with RHD was small, and more than one quarter of children eligible for screening were
not enrolled due to missing consent or repeated absence during screening visits. Moreover, screen-
ing was limited to school-going children. Since school attendance is associated with socio-eco-
nomic status, sampling based on school lists may have further underestimated the burden of
disease. Prevalence must therefore be interpreted with caution. However, schooling rates in Peru
are well above 97%.[26] Second, the number of children with missing consent underlines the
importance of adjustment to non-response. Adjustment to non-response might be responsible for
the lack of statistical significance of the influence of age on RDHwhen sampling weights are con-
sidered because of unequal distribution of non-response across age categories and thus important
differences in means of the sampling weights per age groups. This suggests that the withdrawal of
the consent of participation is linked to age. Third, 14 out of 59 children (24%) with suspicious
findings did not undergo confirmation. A similar drop-out rate has been observed in a previous
study[18] and may questions the applicability of a two-step approach. Finally, estimated preva-
lence is bound to the setting under investigation and cannot be extrapolated to remote rural
regions of Peru, or other regions in Latin America. And finally, the present findings on echocar-
diographic screening have to be interpreted in the context of a relatively low prevalence setting
and cannot be generalized to endemic regions in sub-Saharan Africa, Southeast Asia, and Oceania.
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